Literature DB >> 7541539

Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

G D'Angelo1, I Struman, J Martial, R I Weiner.   

Abstract

A number of factors both stimulating and inhibiting angiogenesis have been described. In the current work, we demonstrate that the angiogenic factor vascular endothelial growth factor (VEGF) activates mitogen-activated protein kinase (MAPK) as has been previously shown for basic fibroblast growth factor. The antiagiogenic factor 16-kDa N-terminal fragment of human prolactin inhibits activation of MAPK distal to autophosphorylation of the putative VEGF receptor, Flk-1, and phospholipase C-gamma. These data show that activation and inhibition of MAPK may play a central role in the control of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541539      PMCID: PMC41520          DOI: 10.1073/pnas.92.14.6374

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.

Authors:  T E Maione; G S Gray; J Petro; A J Hunt; A L Donner; S I Bauer; H F Carson; R J Sharpe
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

Review 2.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

3.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

Authors:  M Shibuya; S Yamaguchi; A Yamane; T Ikeda; A Tojo; H Matsushime; M Sato
Journal:  Oncogene       Date:  1990-04       Impact factor: 9.867

4.  Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor.

Authors:  D K Morrison; D R Kaplan; J A Escobedo; U R Rapp; T M Roberts; L T Williams
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

5.  Characterization of the receptors for vascular endothelial growth factor.

Authors:  N Vaisman; D Gospodarowicz; G Neufeld
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

6.  Microtubule-associated-protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the mitogen-activated MAP kinase of fibroblastic cells.

Authors:  Y Gotoh; E Nishida; T Yamashita; M Hoshi; M Kawakami; H Sakai
Journal:  Eur J Biochem       Date:  1990-11-13

7.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors:  D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase.

Authors:  N G Anderson; J L Maller; N K Tonks; T W Sturgill
Journal:  Nature       Date:  1990-02-15       Impact factor: 49.962

9.  Bacterial production and purification of recombinant human prolactin.

Authors:  N Paris; F Rentier-Delrue; A Defontaine; V Goffin; J J Lebrun; L Mercier; J A Martial
Journal:  Biotechnol Appl Biochem       Date:  1990-08       Impact factor: 2.431

10.  Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor.

Authors:  P L Lee; D E Johnson; L S Cousens; V A Fried; L T Williams
Journal:  Science       Date:  1989-07-07       Impact factor: 47.728

View more
  49 in total

1.  Vascular endothelial growth factor increases Rana vascular permeability and compliance by different signalling pathways.

Authors:  D O Bates; R I Heald; F E Curry; B Williams
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

3.  Differential modulation of cadherin-mediated cell-cell adhesion by platelet endothelial cell adhesion molecule-1 isoforms through activation of extracellular regulated kinases.

Authors:  N Sheibani; C M Sorenson; W A Frazier
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

4.  Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

Authors:  Ngoc-Quynh-Nhu Nguyen; Sebastien P Tabruyn; Laurence Lins; Michelle Lion; Anne M Cornet; Florence Lair; Francoise Rentier-Delrue; Robert Brasseur; Joseph A Martial; Ingrid Struman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

5.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

6.  Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model.

Authors:  Juha P Laurila; Lilja Laatikainen; Maria D Castellone; Parul Trivedi; Jari Heikkila; Ari Hinkkanen; Peiman Hematti; Mikko O Laukkanen
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

7.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 8.  Significance of tumor-host interactions in cancer growth and metastases.

Authors:  R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

Review 9.  Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.

Authors:  Carmen Clapp; Stéphanie Thebault; Gonzalo Martínez de la Escalera
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

10.  MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.

Authors:  Julie Halkein; Sebastien P Tabruyn; Melanie Ricke-Hoch; Arash Haghikia; Ngoc-Quynh-Nhu Nguyen; Michaela Scherr; Karolien Castermans; Ludovic Malvaux; Vincent Lambert; Marc Thiry; Karen Sliwa; Agnes Noel; Joseph A Martial; Denise Hilfiker-Kleiner; Ingrid Struman
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.